Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.

Phase 2CompletedNCT00141128

Pfizer18 enrolled

Overview

SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel methodology

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Sex: FEMALEMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Female * Stress urinary incontinence Exclusion Criteria: * Bladder outflow obstruction * Neurological disease

Pfizer Investigational Site

Glostrup Municipality, Denmark

To assess the utility of urethral reflectometry in the detection of pharmacologically induced pressure changes in the female urethra.

To assess the effect of [S,S]-Reboxetine on urethral function in women with SUI.

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.